NCT00581061View on ClinicalTrials.gov

Study to Determine Effects of Vesicare on Return to Continence Post- Radical Prostatectomy

NATerminatedINTERVENTIONAL

Enrollment

13

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2010

Conditions

Incontinence

Interventions

DRUG

Vesicare

Vesicare will be taken daily for one or three months, depending on symptoms of subject.

Trial Locations (1)

92868

University of California, Irvine Medical Center, Orange

Sponsors

Collaborators (1)

Astellas Pharma Inc

All Listed Sponsors

collaborator

Astellas Pharma Inc

INDUSTRY

lead

University of California, Irvine

OTHER